玻璃体内注射奥克纤溶酶后的板层黄斑裂孔
Lamellar macular hole after intravitreal ocriplasmin injection.
作者信息
Chod Ross Bronson, Goodrich Clifford, Saxena Sandeep, Akduman Levent
机构信息
Department of Ophthalmology, St Louis University Eye Institute, St Louis, Missouri, USA.
Department of Ophthalmology, CSM Medical University, Lucknow, Uttar Pradesh, India.
出版信息
BMJ Case Rep. 2015 Jan 9;2015:bcr2014207810. doi: 10.1136/bcr-2014-207810.
Abstract
Intravitreal ocriplasmin was recently approved by the Food and Drug Administration to achieve medical vitreolysis in the setting of vitreomacular adhesion (VMA). We report a case of a 76-year-old woman who developed a lamellar macular hole following treatment with intravitreal ocriplasmin injection for VMA. A pathophysiological mechanism to explain this previously unreported complication of ocriplasmin injection is proposed.
摘要
玻璃体内注射奥克纤溶酶最近被美国食品药品监督管理局批准用于在玻璃体黄斑粘连（VMA）情况下实现医源性玻璃体溶解。我们报告了一例76岁女性患者，她在接受玻璃体内注射奥克纤溶酶治疗VMA后出现了板层黄斑裂孔。本文提出了一种病理生理机制来解释这种先前未报道的奥克纤溶酶注射并发症。
相似文献
1
Lamellar macular hole after intravitreal ocriplasmin injection.玻璃体内注射奥克纤溶酶后的板层黄斑裂孔
BMJ Case Rep. 2015 Jan 9;2015:bcr2014207810. doi: 10.1136/bcr-2014-207810.
2
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial.2 年 ocriplasmin 治疗伴有黄斑孔的症状性玻璃体黄斑粘连（OASIS）随机试验结果。
Ophthalmology. 2016 Oct;123(10):2232-47. doi: 10.1016/j.ophtha.2016.06.043. Epub 2016 Aug 4.
3
Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin.玻璃体内注射奥克纤溶酶后玻璃体黄斑粘连/牵引松解的基线预测因素
Ophthalmic Surg Lasers Imaging Retina. 2016 Aug 1;47(8):716-23. doi: 10.3928/23258160-20160808-04.
4
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵拉和黄斑裂孔的视觉功能反应
Acta Ophthalmol. 2017 Dec;95(8):e740-e745. doi: 10.1111/aos.13369. Epub 2017 Jan 30.
5
Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment.玻璃体内注射奥克纤溶酶治疗后早期玻璃体黄斑分离伴黄斑裂孔闭合延迟
Indian J Ophthalmol. 2016 Mar;64(3):222-4. doi: 10.4103/0301-4738.181746.
6
Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.在使用奥克纤溶酶治疗症状性玻璃体黄斑粘连/玻璃体黄斑牵拉（包括与黄斑裂孔相关时）的MIVI-TRUST研究中，解剖学分辨率与功能预后之间的关联。
Retina. 2015 Jun;35(6):1151-7. doi: 10.1097/IAE.0000000000000508.
7
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.ocriplasmin 治疗症状性玻璃体黄斑牵引综合征的解剖和视觉结果。
Br J Ophthalmol. 2014 Mar;98(3):356-60. doi: 10.1136/bjophthalmol-2013-304219. Epub 2013 Dec 19.
8
Delayed full-thickness macular hole closure without vitreomacular traction release following ocriplasmin injection.注射奥克纤溶酶后未行玻璃体黄斑牵引松解术而出现的延迟性黄斑全层裂孔闭合。
BMJ Case Rep. 2015 Sep 10;2015:bcr2015212181. doi: 10.1136/bcr-2015-212181.
9
[Clinical evaluation of ocriplasmin as a vitreolytic agent].[玻璃体内溶解剂奥克纤溶酶的临床评估]
Zhonghua Yan Ke Za Zhi. 2015 Feb;51(2):155-60.
10
From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.从药物性玻璃体溶解分析到奥克纤溶酶安全性的理解。
Expert Opin Drug Saf. 2016 Sep;15(9):1267-78. doi: 10.1080/14740338.2016.1208169. Epub 2016 Jul 20.
引用本文的文献
1
[Microstructural retinal changes after pharmacological vitreolysis with ocriplasmin-an SD-OCT supported analysis].[玻璃体内注射奥克纤溶酶后视网膜微观结构变化——基于频域光学相干断层扫描的分析]
Ophthalmologe. 2020 Mar;117(3):260-266. doi: 10.1007/s00347-019-0944-9.
2
Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引和黄斑裂孔：玻璃体脱离预测因素及潜在并发症的荟萃分析与综合综述
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1247-56. doi: 10.1007/s00417-016-3363-5. Epub 2016 Apr 30.
3
Ocriplasmin: who is the best candidate?奥克纤溶酶：最佳适用人群是谁？
Clin Ophthalmol. 2016 Mar 17;10:485-95. doi: 10.2147/OPTH.S97947. eCollection 2016.
4
Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引和黄斑裂孔的真实生活经验：一项频域光学相干断层扫描前瞻性研究。
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):223-33. doi: 10.1007/s00417-015-3031-1. Epub 2015 May 5.
本文引用的文献
1
Retinal breaks due to intravitreal ocriplasmin.玻璃体内注射奥克纤溶酶所致的视网膜裂孔
Clin Ophthalmol. 2014 Aug 25;8:1591-4. doi: 10.2147/OPTH.S68037. eCollection 2014.
2
Three-dimensional spectral domain optical coherence tomography in vitreomacular traction.三维光谱域光学相干断层扫描在玻璃体黄斑牵引中的应用
BMJ Case Rep. 2014 Jun 17;2014:bcr2013202065. doi: 10.1136/bcr-2013-202065.
3
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.用 ocriplasmin 进行酶玻璃体溶解治疗玻璃体黄斑牵引和黄斑裂孔。
N Engl J Med. 2012 Aug 16;367(7):606-15. doi: 10.1056/NEJMoa1110823.
4
A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy.玻璃体切除术前行玻璃体后脱离的微纤维蛋白酶玻璃体腔内注射的安慰剂对照试验。
Ophthalmology. 2010 Apr;117(4):791-7. doi: 10.1016/j.ophtha.2009.11.005.
5
Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.计划接受玻璃体切除术的玻璃体黄斑牵引患者玻璃体内注射微纤溶酶：MIVI I试验
Ophthalmology. 2009 Jul;116(7):1349-55, 1355.e1-2. doi: 10.1016/j.ophtha.2009.03.051. Epub 2009 May 17.
6
Posterior vitreous detachment induced by microplasmin.微纤溶酶诱导的玻璃体后脱离
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):641-7. doi: 10.1167/iovs.03-0930.
7
Tomographic features of a lamellar macular hole formation and a lamellar hole that progressed to a full-thickness macular hole.板层黄斑裂孔形成以及进展为全层黄斑裂孔的板层裂孔的断层扫描特征。
Am J Ophthalmol. 2000 Nov;130(5):677-9. doi: 10.1016/s0002-9394(00)00626-7.
8
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.纤溶酶原激活剂（尿激酶）、纤溶酶和凝血酶对基底膜糖蛋白和胶原成分的影响。
Cancer Res. 1981 Nov;41(11 Pt 1):4629-36.
9
Age-related changes in human vitreous structure.人类玻璃体结构的年龄相关变化。
Graefes Arch Clin Exp Ophthalmol. 1987;225(2):89-93. doi: 10.1007/BF02160337.
10
Surgical excision of the attached posterior hyaloid.附着的后玻璃体膜的手术切除。
Arch Ophthalmol. 1988 Jul;106(7):998-1000. doi: 10.1001/archopht.1988.01060140144042.
Zotero 插件